| Bioactivity | MSI-1701 is an analogue of MSI-1436 which can control weight gain and blood glucose level extracted from patent US 7410959 B1. | ||||||||||||
| In Vivo | Analogues that differ from MSI-1436 at only a single stereocenter, such as MSI-1701 (the polyamine at C-3) or MSI-1777 (the methyl at C-20) exhibit significantly reduced activity, while MSI-1673 (the OH at C-7) is completely inactive[1]. | ||||||||||||
| Name | MSI-1701 | ||||||||||||
| CAS | 390808-64-7 | ||||||||||||
| Formula | C37H72N4O5S | ||||||||||||
| Molar Mass | 685.06 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Michael Zasloff, et al. Therapeutic uses for aminosterol compounds. US 7410959 B1. |
MSI-1701
CAS: 390808-64-7 F: C37H72N4O5S W: 685.06
MSI-1701 is an analogue of MSI-1436 which can control weight gain and blood glucose level extracted from patent US 74109
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.